Literature DB >> 11024397

Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings.

E Y Chakhtoura1, F E Shamoon, J I Haft, G R Obiedzinski, A J Cohen, R M Watson.   

Abstract

We sought to investigate the relation between platelet activation and the angiographic evidence of ruptured plaque in patients presenting with unstable and stable angina pectoris. We prospectively enrolled 25 consecutive patients (5 women and 20 men, mean age 62 +/- 3 years), 17 with unstable angina and 8 with stable angina. Systemic venous blood samples were collected within 4 to 6 hours of admission for flow cytometry analysis. Activation-dependent epitope CD63 and glycoprotein IIb/IIIa on the platelet membrane were assayed. Fibrinogen levels were also measured. All patients with unstable angina underwent cardiac catheterization and had angiographic evidence of ruptured plaque. Of the patients with stable angina, 5 underwent coronary angiography with smooth noncomplex lesions and 3 had negative technetium-99m sestamibi stress tests. Patients with unstable angina were characterized by 39% higher levels of fibrinogen than patients with stable angina (423 +/- 304 vs 304 +/- 51 mg/dl, p = 0.004). The percentage of platelets positive for the activation-dependent epitope CD63 was 5 times higher in patients with unstable than stable angina (14.6 +/- 5.6% vs 2.75 +/- 1.6%, p = 0.0026). They also had a 15% higher expression of their glycoprotein IIb/IIIa (517 +/- 79 vs 449 +/- 50 mean fluorescence intensity, p = 0.038). Thus, this study establishes a direct relation between the morphology of ruptured plaque and platelet activation in patients with unstable angina. This may allow for further risk stratification. Patients with unstable complex lesions had a fivefold higher expression of the platelet activation epitope CD63 than patients with stable angina. Furthermore, they had 15% more glycoprotein IIb/IIIa aggregation sites expressed on their platelet membrane, thus indicating an intense thrombogenic potential.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024397     DOI: 10.1016/s0002-9149(00)01102-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Platelet reactivity and the identification of acute coronary syndromes in the emergency department.

Authors:  Chad E Darling; Alan D Michelson; Gregory A Volturo; Karin Przyklenk
Journal:  J Thromb Thrombolysis       Date:  2008-07-04       Impact factor: 2.300

2.  Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.

Authors:  Shengcun Guo; Shuxin Shen; Junfen Wang; He Wang; Meiyu Li; Ying Liu; Fanfan Hou; Yulin Liao; Jianping Bin
Journal:  Theranostics       Date:  2015-02-05       Impact factor: 11.556

3.  Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling.

Authors:  Eduardo Fuentes; Jaime Pereira; Diego Mezzano; Marcelo Alarcón; Julio Caballero; Iván Palomo
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

4.  Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina.

Authors:  Ruijun Peng; Xili Yang; Xi Liang
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

Review 5.  Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases.

Authors:  Enrico Lupia; Alberto Goffi; Ornella Bosco; Giuseppe Montrucchio
Journal:  Mediators Inflamm       Date:  2012-04-05       Impact factor: 4.711

Review 6.  Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products.

Authors:  Eduardo Fuentes; Iván Palomo
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.